SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Spyre reported positive Phase 2 SKYLINE data for SPY003, a potential best-in-class anti-IL-23. The results met its endpoints with clinically meaningfu...
1606 Corp. executed a Letter of Intent with EthosEnergy O&M to manage the Lufkin facility. The deal will support the planned acquisition and operation...
Arrive AI reported fiscal Q3 results recently, highlighting its operating activities within the electric vehicle sector while disclosing financial per...
GE Aerospace agreed to acquire Consolidated Precision Products for $11.75 billion, a deal expected to close by late 2027. This acquisition supports ai...
Group 1 Automotive announced a $1.25 billion offering of senior unsecured notes due 2032 and 2035, intended to fund its acquisition of certain dealers...
IonQ raised its 2026 revenue outlook to between $450M and $460M, anticipating substantial contributions from its recently acquired SkyWater Technology...
Pyxis Oncology appointed Thomas Civik as its new CEO and Chairman following his tenure as Interim CEO. The leadership transition sets the stage for ad...
The company announced invitations to its 2026 Investor Meetings, scheduled for September 2026. This meeting serves to discuss future markets, demand f...
PMI raised its reported diluted EPS forecast for currency only to $7.28-$7.43 for 2026, largely due to favorable currency expectations. The adjusted d...
Company reveals Q3 results and BLA targeting datalimogene for urology; cash balance reported at $266 million....
United Community Banks announced the completion of a $2.6B investment securities portfolio repositioning, offset by a $300M pre-tax loss, while mainta...
Soluna Holdings, Inc. energized the final 14 MW of its Project Kati 1 in Texas, and has received a conditional Base Load classification from ERCOT for...
Rigetti Computing Inc. announced a $100 million Other Transaction Agreement with the U.S. Department of Commerce for advanced microelectronics researc...
X4 Pharmaceuticals secured FDA agreement to reduce its late-stage trial enrollment by 126 patients, with data expected mid-2028. This regulatory align...
Tonix Pharmaceuticals has promoted Thomas Englese to Chief Commercial Officer following his instrumental role in the U.S. launch of TONMYA. The manage...
ABM reported record quarterly revenue and adjusted EPS, leading the company to raise its full-year adjusted EPS and free cash flow outlook....
Kiora Pharmaceuticals Inc. appointed Keith Lane as Executive Vice President, Head of Clinical Development and Regulatory Affairs, with a starting sala...
Willis Lease Finance Corporation (WLFC) introduced an integrated aviation platform and plans to invest in engines. The announcement serves as a forwar...
Monte Rosa Therapeutics announced a $50 million milestone payment from collaborator Novartis regarding a global Phase 2 clinical study of MRT-6160 for...
United Natural Foods reported full-year 2026 net sales of $31.2 billion and adjusted EBITDA of $701 million, raising fiscal 2027 guidance to high sing...